CJC-1295 with DAC
Preclinical — Animal / cell-model data onlyWhat it is
A CJC-1295 variant with drug-affinity complex (DAC) extending its half-life to days rather than minutes.
CJC-1295 with DAC carries a drug-affinity complex that extends its half-life to days, giving a sustained (rather than pulsatile) GH elevation.
Research context
Studied in relation to:
- Sustained GH-release research
Points in its favour in the literature:
- Long-acting single-compound option
Caveats and unknowns:
- Sustained GH elevation is less physiological
- Little human data
- Prohibited in sport
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature.
Reported half-life~6–8 days
Published clinical / research context (not instructions)Reported research ~1–2 mg once or twice weekly (long-acting).
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 5 mg vial + 2 mL → 2.5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 5mg | CD5 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.